Michal Juraska

12PUBLICATIONS
99CO-AUTHORS
Molecular evolutionGenetic immunologyMolecular targetsInfectious diseasesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 25, 2026
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Jun 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development.

Peter B Gilbert, James Peng, Larry Han

|Nov 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Lindsay N Carpp, Ollivier Hyrien, Youyi Fong

|Mar 23, 2024
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Daniel B Reeves, Bryan T Mayer, Allan C deCamp

|Mar 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Craig A Magaret, Li Li, Allan C deCamp

Pageof 2

Frequent Collaborators

11 joint publications

Lawrence Corey

10 joint publications

Peter Gilbert

8 joint publications

Lindsay N Carpp

7 joint publications

Craig Magaret